Annexon bolsters ophthalmology expertise with appointment of retina specialist lloyd clark, m.d., as pivotal anx007 program advances in dry age-related macular degeneration (amd) with geographic atrophy (ga)

Dr. clark brings 25 years of experience treating retina diseases and developing emerging therapies as a principal investigator in over 70 clinical trials and as an early pioneer of vegf inhibitors
AMD Ratings Summary
AMD Quant Ranking